• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单侧甲状腺乳头状癌术前临床特征的列线图模型预测对侧中等体积中央淋巴结转移。

Nomogram model based on preoperative clinical characteristics of unilateral papillary thyroid carcinoma to predict contralateral medium-volume central lymph node metastasis.

机构信息

Department of Oncological Surgery, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, Zhejiang, China.

The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

出版信息

Front Endocrinol (Lausanne). 2024 Feb 12;14:1271446. doi: 10.3389/fendo.2023.1271446. eCollection 2023.

DOI:10.3389/fendo.2023.1271446
PMID:38415181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10897970/
Abstract

OBJECTIVES

To explore the preoperative high-risk clinical factors for contralateral medium-volume central lymph node metastasis (conMVCLNM) in unilateral papillary thyroid carcinoma (uPTC) and the indications for dissection of contralateral central lymph nodes (conCLN).

METHODS

Clinical and pathological data of 204 uPTC patients who underwent thyroid surgery at the Hangzhou First People's Hospital from September 2010 to October 2022 were collected. Univariate and multivariate logistic regression analyses were conducted to determine the independent risk factors for contralateral central lymph node metastasis (conCLNM) and conMVCLNM in uPTC patients based on the preoperative clinical data. Predictive models for conCLNM and conMVCLNM were constructed using logistic regression analyses and validated using receiver operating characteristic (ROC) curves, concordance index (C-index), calibration curves, and decision curve analysis (DCA).

RESULTS

Univariate and multivariate logistic regression analyses showed that gender (P < 0.001), age (P < 0.001), tumor diameter (P < 0.001), and multifocality (P = 0.008) were independent risk factors for conCLNM in uPTC patients. Gender(P= 0.026), age (P = 0.010), platelet-to-lymphocyte ratio (PLR) (P =0.003), and tumor diameter (P = 0.036) were independent risk factors for conMVCLNM in uPTC patients. A predictive model was established to assess the risk of conCLNM and conMVCLNM, with ROC curve areas of 0.836 and 0.845, respectively. The C-index, the calibration curve, and DCA demonstrated that the model had good diagnostic value.

CONCLUSION

Gender, age, tumor diameter, and multifocality are high-risk factors for conCLNM in uPTC patients. Gender, age, tumor diameter, and PLR are high-risk factors for conMVCLNM in uPTC patients, and preventive conCLN dissection should be performed.

摘要

目的

探讨单侧甲状腺乳头状癌(uPTC)患者对侧中体积中央淋巴结转移(conMVCLNM)的术前高危临床因素及对侧中央淋巴结(conCLN)清扫的适应证。

方法

收集 2010 年 9 月至 2022 年 10 月杭州市第一人民医院甲状腺外科手术的 204 例 uPTC 患者的临床病理资料。基于术前临床资料,采用单因素和多因素逻辑回归分析确定 uPTC 患者对侧中央淋巴结转移(conCLNM)和 conMVCLNM 的独立危险因素。使用逻辑回归分析构建 conCLNM 和 conMVCLNM 的预测模型,并使用受试者工作特征(ROC)曲线、一致性指数(C 指数)、校准曲线和决策曲线分析(DCA)进行验证。

结果

单因素和多因素逻辑回归分析表明,性别(P<0.001)、年龄(P<0.001)、肿瘤直径(P<0.001)和多灶性(P=0.008)是 uPTC 患者 conCLNM 的独立危险因素。性别(P=0.026)、年龄(P=0.010)、血小板与淋巴细胞比值(PLR)(P=0.003)和肿瘤直径(P=0.036)是 uPTC 患者 conMVCLNM 的独立危险因素。建立了一个预测模型来评估 conCLNM 和 conMVCLNM 的风险,ROC 曲线下面积分别为 0.836 和 0.845。C 指数、校准曲线和 DCA 表明该模型具有良好的诊断价值。

结论

性别、年龄、肿瘤直径和多灶性是 uPTC 患者 conCLNM 的高危因素。性别、年龄、肿瘤直径和 PLR 是 uPTC 患者 conMVCLNM 的高危因素,应预防性清扫对侧中央淋巴结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/caac3668ae80/fendo-14-1271446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/22c9907e905e/fendo-14-1271446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/0a9f3019dc71/fendo-14-1271446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/caac3668ae80/fendo-14-1271446-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/22c9907e905e/fendo-14-1271446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/0a9f3019dc71/fendo-14-1271446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae7/10897970/caac3668ae80/fendo-14-1271446-g006.jpg

相似文献

1
Nomogram model based on preoperative clinical characteristics of unilateral papillary thyroid carcinoma to predict contralateral medium-volume central lymph node metastasis.基于单侧甲状腺乳头状癌术前临床特征的列线图模型预测对侧中等体积中央淋巴结转移。
Front Endocrinol (Lausanne). 2024 Feb 12;14:1271446. doi: 10.3389/fendo.2023.1271446. eCollection 2023.
2
[Risk factors analysis and prediction model establishment of contralateral central lymph node metastasis in intermediate-to-high risk unilateral papillary thyroid carcinoma].[中高危单侧甲状腺乳头状癌对侧中央区淋巴结转移的危险因素分析及预测模型建立]
Zhonghua Yi Xue Za Zhi. 2024 Sep 24;104(36):3416-3421. doi: 10.3760/cma.j.cn112137-20240524-01180.
3
Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.建立预测甲状腺微小乳头状癌中央区淋巴结转移的列线图。
BMC Cancer. 2024 Feb 20;24(1):235. doi: 10.1186/s12885-024-12004-3.
4
Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.基于列线图的孤立峡部型甲状腺微小乳头状癌中央区淋巴结转移风险预测:一项 2010 年至 2021 年的回顾性研究。
Front Endocrinol (Lausanne). 2023 Jan 17;13:1098204. doi: 10.3389/fendo.2022.1098204. eCollection 2022.
5
Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.术前预测 cN0T1/T2 期甲状腺乳头状癌中央区淋巴结转移:基于临床和超声特征的列线图
Eur J Surg Oncol. 2022 Jun;48(6):1272-1279. doi: 10.1016/j.ejso.2022.04.001. Epub 2022 Apr 6.
6
Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.预测临床淋巴结阴性的孤立峡部经典型乳头状甲状腺癌患者对侧和同侧中央淋巴结转移的列线图。
Surgery. 2021 Dec;170(6):1670-1679. doi: 10.1016/j.surg.2021.06.027. Epub 2021 Jul 16.
7
Glucose-to-Lymphocyte Ratio (GLR) as a Predictor of Preoperative Central Lymph Node Metastasis in Papillary Thyroid Cancer Patients With Type 2 Diabetes Mellitus and Construction of the Nomogram.葡萄糖/淋巴细胞比值(GLR)预测 2 型糖尿病合并甲状腺乳头状癌患者术前中央区淋巴结转移及列线图的构建。
Front Endocrinol (Lausanne). 2022 Apr 26;13:829009. doi: 10.3389/fendo.2022.829009. eCollection 2022.
8
Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.基于术前血清甲状腺球蛋白和甲状腺乳头状癌临床特征的列线图模型预测颈部淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 15;13:937049. doi: 10.3389/fendo.2022.937049. eCollection 2022.
9
Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.构建基于甲状腺结节和细针穿刺活检可疑侧颈部淋巴结分布的列线图预测甲状腺乳头状癌转移。
Front Endocrinol (Lausanne). 2023 Nov 28;14:1242061. doi: 10.3389/fendo.2023.1242061. eCollection 2023.
10
Machine learning algorithms for identifying contralateral central lymph node metastasis in unilateral cN0 papillary thyroid cancer.用于识别单侧 cN0 甲状腺乳头状癌中央淋巴结转移的机器学习算法。
Front Endocrinol (Lausanne). 2024 May 10;15:1385324. doi: 10.3389/fendo.2024.1385324. eCollection 2024.

引用本文的文献

1
A nomogram for individualized prediction for cervical lymph node metastasis of papillary thyroid carcinoma.一种用于个体化预测甲状腺乳头状癌颈部淋巴结转移的列线图。
Gland Surg. 2024 Nov 30;13(11):1965-1976. doi: 10.21037/gs-24-277. Epub 2024 Nov 26.

本文引用的文献

1
A retrospective study of factors affecting contralateral central-neck lymph node metastasis in unilateral papillary thyroid carcinoma.回顾性研究影响单侧甲状腺乳头状癌对侧中央颈部淋巴结转移的因素。
Asian J Surg. 2023 Sep;46(9):3485-3490. doi: 10.1016/j.asjsur.2022.10.081. Epub 2022 Nov 10.
2
Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma.淋巴结清扫对甲状腺癌患者全甲状腺切除术后并发症的影响
Cancers (Basel). 2022 Nov 7;14(21):5462. doi: 10.3390/cancers14215462.
3
Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
cN0 期甲状腺微小乳头状癌高容量中央区淋巴结转移的临床及超声危险因素:一项回顾性研究与Meta分析
Clin Endocrinol (Oxf). 2023 Apr;98(4):609-621. doi: 10.1111/cen.14834. Epub 2022 Nov 3.
4
Blood immune indexes can predict lateral lymph node metastasis of thyroid papillary carcinoma.血液免疫指标可预测甲状腺乳头状癌的侧颈淋巴结转移。
Front Endocrinol (Lausanne). 2022 Aug 31;13:995630. doi: 10.3389/fendo.2022.995630. eCollection 2022.
5
Prognostic significance of inflammatory markers LMR, PLR, MPV, FIB in intermediate-and high-risk papillary thyroid carcinoma.炎症标志物 LMR、PLR、MPV、FIB 在中高危甲状腺乳头状癌中的预后意义。
Front Endocrinol (Lausanne). 2022 Aug 18;13:984157. doi: 10.3389/fendo.2022.984157. eCollection 2022.
6
Pretracheal Lymph Node Subdivision in Predicting Contralateral Central Lymph Node Metastasis for Unilateral Papillary Thyroid Carcinoma: Preliminary Results.甲状腺癌术前气管前淋巴结分区与预测单侧甲状腺乳头状癌中央区淋巴结转移的关系:初步研究结果
Front Endocrinol (Lausanne). 2022 Jul 18;13:921845. doi: 10.3389/fendo.2022.921845. eCollection 2022.
7
Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study.炎症标志物在预测甲状腺乳头状癌患者复发方面具有重要价值:一项长期随访的回顾性研究。
Cancer Control. 2022 Jan-Dec;29:10732748221115236. doi: 10.1177/10732748221115236.
8
Artificial Neural Network-Based Ultrasound Radiomics Can Predict Large-Volume Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients.基于人工神经网络的超声影像组学可预测临床N0期甲状腺乳头状癌患者的大体积淋巴结转移
J Oncol. 2022 Jun 17;2022:7133972. doi: 10.1155/2022/7133972. eCollection 2022.
9
Prophylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence: A Meta-analysis of Randomized Trials.预防性中央区颈淋巴结清扫术在低危甲状腺癌患者中并不能降低局部区域复发率:一项随机试验的荟萃分析。
Ann Surg. 2022 Jul 1;276(1):66-73. doi: 10.1097/SLA.0000000000005388. Epub 2022 Jan 24.
10
Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC).肿瘤内低基因中性粒细胞与淋巴细胞比值(NLR)与三阴性乳腺癌(TNBC)良好的肿瘤免疫微环境及生存相关。
Am J Cancer Res. 2021 Nov 15;11(11):5743-5755. eCollection 2021.